Pratip K Chattopadhyay
Overview
Explore the profile of Pratip K Chattopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
5013
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freeman D, Diefenbach C, Lam L, Le T, Alexandre J, Raphael B, et al.
Cell Rep
. 2024 Aug;
43(8):114605.
PMID: 39128003
Immune cells express an incredible variety of proteins; by measuring combinations of these, cell types influencing disease can be precisely identified. We developed terraFlow, a platform that defines cell subsets...
2.
Chattopadhyay P
Methods Cell Biol
. 2024 May;
186:249-270.
PMID: 38705602
Molecular cytometry refers to a group of high-parameter technologies for single-cell analysis that share the following traits: (1) combined (multimodal) measurement of protein and transcripts, (2) medium throughput (10-100K cells),...
3.
Wan S, Zhao E, Freeman D, Weissinger D, Krantz B, Werba G, et al.
Front Immunol
. 2023 Apr;
14:1177713.
PMID: 37033968
[This corrects the article DOI: 10.3389/fimmu.2023.1067352.].
4.
Melani C, Dowdell K, Pittaluga S, Dunleavy K, Roschewski M, Song J, et al.
Lancet Haematol
. 2023 Apr;
10(5):e346-e358.
PMID: 37011643
Background: Lymphomatoid granulomatosis is a rare Epstein-Barr virus-associated B-cell lymphoproliferative disorder with a median overall survival of less than 2 years. In this study, we hypothesised that low-grade lymphomatoid granulomatosis...
5.
Wan S, Zhao E, Weissinger D, Krantz B, Werba G, Freeman D, et al.
Front Immunol
. 2023 Feb;
14:1067352.
PMID: 36798126
Hepato-pancreatico-biliary (HPB) malignancies are difficult-to-treat and continue to to have a high mortality and significant therapeutic resistance to standard therapies. Immune oncology (IO) therapies have demonstrated efficacy in several solid...
6.
Corselli M, Saksena S, Nakamoto M, Lomas 3rd W, Taylor I, Chattopadhyay P
Cytometry A
. 2021 Aug;
101(1):27-44.
PMID: 34390166
T-cell activation is a key step in the amplification of an immune response. Over the course of an immune response, cells may be chronically stimulated, with some proportion becoming exhausted;...
7.
Chattopadhyay P, Filby A, Jellison E, Ferrari G, Green C, Cherian S, et al.
Cytometry A
. 2020 Sep;
99(1):11-18.
PMID: 32881296
Cytometry is playing a crucial role in addressing the COVID-19 pandemic. In this commentary-written by a variety of stakeholders in the cytometry, immunology, and infectious disease communities-we review cytometry's role...
8.
Woods D, Laino A, Winters A, Alexandre J, Freeman D, Rao V, et al.
JCI Insight
. 2020 May;
5(11).
PMID: 32369447
BACKGROUNDThe reshaping of the immune landscape by nivolumab (NIVO) and ipilimumab (IPI) and its relation to patient outcomes is not well described.METHODSWe used high-parameter flow cytometry and a computational platform,...
9.
Cossarizza A, Chang H, Radbruch A, Acs A, Adam D, Adam-Klages S, et al.
Eur J Immunol
. 2019 Oct;
49(10):1457-1973.
PMID: 31633216
These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical aspects of flow cytometry...
10.
Chattopadhyay P, Chiu D
Lab Chip
. 2019 Oct;
19(21):3573-3574.
PMID: 31591632
No abstract available.